These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


341 related items for PubMed ID: 11598557

  • 1. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S, Fekih M, Chaïeb A, Bibi M, Mellouli R, Khaïri H.
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [Abstract] [Full Text] [Related]

  • 2. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS, Savage K, Lincoln T, Owen J.
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA, Hannah ME, Chitayat D, Thomas M, Winsor E, Ferris LE, Einarson TR, Seaward PG, Ryan G, Willan AR, Windrim R.
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [Abstract] [Full Text] [Related]

  • 4. Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy.
    Kelekci S, Erdemoglu E, Inan I.
    Acta Obstet Gynecol Scand; 2006 Mar; 85(7):825-9. PubMed ID: 16817081
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF, Javed I, Shuja S, Shoaib T, Bano K, Waheed S, Ansar A.
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [Abstract] [Full Text] [Related]

  • 6. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y, Chanrachakul B, Punyavachira P.
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [Abstract] [Full Text] [Related]

  • 7. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
    Kapp N, Todd CS, Yadgarova KT, Alibayeva G, Nazarova D, Loza O, Babadjanova GS.
    Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
    [Abstract] [Full Text] [Related]

  • 8. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
    Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW.
    Obstet Gynecol; 1997 Nov; 90(5):735-8. PubMed ID: 9351755
    [Abstract] [Full Text] [Related]

  • 9. Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination.
    Mahjabeen, Khawaja NP, Rehman R.
    J Coll Physicians Surg Pak; 2009 Jun; 19(6):359-62. PubMed ID: 19486574
    [Abstract] [Full Text] [Related]

  • 10. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS, Lau WN, Chan CC, Ho PC.
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [Abstract] [Full Text] [Related]

  • 11. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.
    Ho PC, Chan YF, Lau W.
    Contraception; 1996 May; 53(5):281-3. PubMed ID: 8724617
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic termination of second trimester pregnancy with vaginal misoprostol.
    Pongsatha S, Tongsong T, Suwannawut O.
    J Med Assoc Thai; 2001 Apr; 84(4):515-9. PubMed ID: 11460962
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.
    Dickinson JE, Godfrey M, Evans SF.
    J Matern Fetal Med; 1998 Apr; 7(3):115-9. PubMed ID: 9642607
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC, Kapp N, Vragpvoc O, Borgata L.
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [Abstract] [Full Text] [Related]

  • 16. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL, Torres MA, Reyes R, Ortega L, García-Gallego F, Sánchez C.
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [Abstract] [Full Text] [Related]

  • 17. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N, Saha SP, Ghoshroy SC, Bhowmik S, Barui G.
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [Abstract] [Full Text] [Related]

  • 18. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK, Mukherji J, Kamilya GS, Ray S, Hazra A.
    Acta Obstet Gynecol Scand; 2006 Apr; 85(12):1458-62. PubMed ID: 17260222
    [Abstract] [Full Text] [Related]

  • 19. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
    Yilmaz B, Kelekci S, Ertas IE, Kahyaoglu S, Ozel M, Sut N, Danisman N.
    Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
    [Abstract] [Full Text] [Related]

  • 20. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.